Anzeige
Mehr »
Samstag, 04.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PXUH | ISIN: FR0013470168 | Ticker-Symbol: IM11
Frankfurt
03.10.25 | 08:17
0,421 Euro
+8,51 % +0,033
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANET SA Chart 1 Jahr
5-Tage-Chart
IMPLANET SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,4380,44910:33

Aktuelle News zur IMPLANET Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.09.IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot Spine Surgery System334Strengthening the commercialization strategy for cobotic1 solutions in orthopedic surgery Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology...
► Artikel lesen
16.09.IMPLANET Announces First-Half 2025 Results283First-half revenue up 41% to €5.8 million 16% improvement in net result from continuing operations Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME)...
► Artikel lesen
15.07.IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China341Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
08.07.IMPLANET Announces Half-Year Revenue for 2025 up 41% to €5.8 Million949Second quarter 2025 up +71% to €3.2 millions Revenue in the United States increased by a factor of 5.4 in Q2 2025 and by 1.7x for the first half of 2025 compared to 2024 Strong first...
► Artikel lesen
IMPLANET Aktie jetzt für 0€ handeln
24.04.IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics' Next-Gen Robotic Solutions at AANS in Boston344Spine tech innovator IMPLANET will demo and display its game-changing portfolio in tandem with 8i Robotics' robot systems at Booth #1029, April 25-28, 2025 Regulatory News: At this year's American...
► Artikel lesen
14.04.Minutes of IMPLANET's Annual General Meeting Held on April 11, 2025511Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, éligible PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
09.04.IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%336+16% revenue growth compared to Q1 2024 Performance driven by strong export growth outside France and the United States (+42% vs. Q1 2024) Regulatory News: IMPLANET (Euronext Growth:...
► Artikel lesen
04.03.IMPLANET Reports Its 2024 Full-Year Results5572024 full-year revenue up +26% compared to fiscal year 2023 Continued strict control of operational costs throughout the period Regulatory News: IMPLANET (Euronext Growth: ALIMP,...
► Artikel lesen
14.01.IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million451Continued acceleration in quarterly revenue growth since Q2 2024, with Q4 2024 reaching nearly €3.0 million, up 81% versus 2023 Strong full-year performance in the medical equipment distribution...
► Artikel lesen
06.01.IMPLANET Announces Its 2025 Financial Calendar563Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the...
► Artikel lesen
05.12.24IMPLANET Announces Financing of Around €2 Million500Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the...
► Artikel lesen
08.10.24IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth496Revenue for the first nine months of 2024: €6.4 million, a 11% increase compared to the same period last year First delivery of Olea equipment worth €0.5 million completed in the United...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1